MacroGenics
MGNX
#8505
Rank
HK$1.47 B
Marketcap
HK$23.20
Share price
-3.90%
Change (1 day)
36.96%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -HK$0.43

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -HK$0.39. In 2024 the company made an earnings per share (EPS) of -HK$8.39 a decrease over its 2023 EPS that were of -HK$1.18.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$0.43-94.83%
2024-HK$8.39613.33%
2023-HK$1.18-92.31%
2022-HK$15.28-42.14%
2021-HK$26.4136.44%
2020-HK$19.36-21.84%
2019-HK$24.77-24.58%
2018-HK$32.84675.93%
2017-HK$4.23-68.05%
2016-HK$13.25168.25%
2015-HK$4.94-55%
2014-HK$10.973400%
2013-HK$0.31-108.68%
2012HK$3.6124.49%
2011HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.66-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.43-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.32-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$51.10-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.28-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$13.87 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA